Molecular thyroid testing

Active Blanket Purchase Agreement Awarded Last action

Contract number
36C25926A0047
Awardee
Awarding agency
Task orders
1 $230,000 obligated

Award facts

Opportunity
Combined order value
$230,000 Current and potential, with all options
Last date to order 1% complete
IDV ceiling 23% used
$1,008,000.00
Maximum order
$250,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
NAICS code
621511 Medical Laboratories
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

Veterans Integrated Service Network 19 established a Blanket Purchase Agreement with Cytopath Biopsy Lab Inc. on September 25, 2026, for molecular thyroid testing, with a ceiling of $1,008,000 and an ultimate completion date of September 24, 2031.

The BPA was established against solicitation requirements for molecular testing services for thyroid specimens at the Rocky Mountain Regional VA Medical Center in Aurora, Colorado, with performance location at Port Chester, New York. The procurement seeks molecular assay testing to analyze thyroid fine needle aspiration specimens classified as Bethesda III or Bethesda IV to classify results as benign or suspicious for malignancy. Testing must detect genetic alterations including mutations, insertions, deletions, gene fusions, chromosomal copy alterations, and mRNA expression profiles using ThyroSeq genomic sequencing technology. The contractor must maintain current CLIA certification, CAP accreditation, and Medicare/Medicaid approval; comply with HIPAA requirements; and report results within 14 days of specimen receipt with Monday-Saturday testing availability. The contractor supplies specimen collection materials, shipping containers, packaging supplies, and courier transportation.

The BPA structure comprises a base year (September 1, 2026 through August 31, 2027) plus four option years. NAICS code 621511 (Medical Laboratories) applies, with PSC Q301 (Reference Laboratory Testing). Award was made on an all-or-nothing, best-value basis weighing technical capability, past performance, and price.

A $230,000 BPA call was issued on September 25, 2026, for first-year molecular thyroid testing funding, running through September 24, 2027, at Port Chester, New York.

Task orders

Task order Ordering agency Obligated Awarded
Molecular thyroid testing first year funding RMR VA 36C25926N0501 Veterans Integrated Service Network 19 (VHA) $230,000

Quick answers

Who was awarded contract 36C25926A0047?

36C25926A0047 was awarded to Cytopath Biopsy Lab Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on September 25, 2026.

How much is contract 36C25926A0047 worth?

Orders under 36C25926A0047 have obligated $230,000. 36C25926A0047's own ceiling is $1,008,000. A single order can be worth up to $250,000.

How many orders have been placed under contract 36C25926A0047?

1 order has been placed under 36C25926A0047, the latest on September 25, 2026.

Who can order from contract 36C25926A0047?

36C25926A0047 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV